Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Epigenetic Modifications in Systemic Sclerosis: A Druggable Target
John Henderson, J.H.W. Distler, Steven O’Reilly
Trends in Molecular Medicine (2019) Vol. 25, Iss. 5, pp. 395-411
Closed Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Emerging role of vitamin D in autoimmune diseases: An update on evidence and therapeutic implications
Giuseppe Murdaca, Alessandro Tonacci, Simone Negrini, et al.
Autoimmunity Reviews (2019) Vol. 18, Iss. 9, pp. 102350-102350
Closed Access | Times Cited: 245
The Role of Myofibroblasts in Physiological and Pathological Tissue Repair
Ronen Schuster, Fereshteh S. Younesi, Maya Ezzo, et al.
Cold Spring Harbor Perspectives in Biology (2022) Vol. 15, Iss. 1, pp. a041231-a041231
Open Access | Times Cited: 106
The Role of microRNAs in Organismal and Skin Aging
Marta Gerasymchuk, Viktoriia Cherkasova, Olga Kovalchuk, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5281-5281
Open Access | Times Cited: 83
Advances in epigenetics in systemic sclerosis: molecular mechanisms and therapeutic potential
Pei‐Suen Tsou, John Varga, Steven O’Reilly
Nature Reviews Rheumatology (2021) Vol. 17, Iss. 10, pp. 596-607
Closed Access | Times Cited: 80
Role of microRNA in the pathogenesis of systemic sclerosis tissue fibrosis and vasculopathy
Tyler W. Henry, Fabian A. Mendoza, Sergio A. Jiménez
Autoimmunity Reviews (2019) Vol. 18, Iss. 11, pp. 102396-102396
Closed Access | Times Cited: 66
Metabolic reprogramming of glycolysis and glutamine metabolism are key events in myofibroblast transition in systemic sclerosis pathogenesis
John Henderson, Laura Duffy, Richard Stratton, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 23, pp. 14026-14038
Open Access | Times Cited: 50
HDAC5-mediated Smad7 silencing through MEF2A is critical for fibroblast activation and hypertrophic scar formation
Ya Gao, Yang Liu, Danning Zheng, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 15, pp. 5724-5739
Open Access | Times Cited: 34
Epigenetics as a versatile regulator of fibrosis
Yang Liu, Dongsheng Wen, Chiakang Ho, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 22
CXCL4 Links Inflammation and Fibrosis by Reprogramming Monocyte-Derived Dendritic Cells in vitro
Sandra C. Silva‐Cardoso, Weiyang Tao, Chiara Angiolilli, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 43
Association Between DNA Damage Response, Fibrosis and Type I Interferon Signature in Systemic Sclerosis
Nikolaos I. Vlachogiannis, Μαρία Παππά, Panagiotis A. Ntouros, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 41
MSCs-laden injectable self-healing hydrogel for systemic sclerosis treatment
Min Nie, Bin Kong, Guopu Chen, et al.
Bioactive Materials (2022) Vol. 17, pp. 369-378
Open Access | Times Cited: 25
Interleukin-11 and its eminent role in tissue fibrosis: a possible therapeutic target
Steven O’Reilly
Clinical & Experimental Immunology (2023) Vol. 214, Iss. 2, pp. 154-161
Open Access | Times Cited: 13
Current and future perspectives on management of systemic sclerosis-associated interstitial lung disease
Oliver Distler, Elizabeth R. Volkmann, Anna‐Maria Hoffmann‐Vold, et al.
Expert Review of Clinical Immunology (2019) Vol. 15, Iss. 10, pp. 1009-1017
Open Access | Times Cited: 39
Current and Potential New Targets in Systemic Sclerosis Therapy: a New Hope
Monique Hinchcliff, Steven O’Reilly
Current Rheumatology Reports (2020) Vol. 22, Iss. 8
Open Access | Times Cited: 37
Antifibrotic factor KLF4 is repressed by the miR-10/TFAP2A/TBX5 axis in dermal fibroblasts: insights from twins discordant for systemic sclerosis
Maya Malaab, Ludivine Renaud, Naoko Takamura, et al.
Annals of the Rheumatic Diseases (2021) Vol. 81, Iss. 2, pp. 268-277
Open Access | Times Cited: 29
Novel Concepts in Systemic Sclerosis Pathogenesis: Role for miRNAs
Iulia Szabo, Laura Muntean, Tania O. Crişan, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1471-1471
Open Access | Times Cited: 27
Histone deacetylase inhibition mitigates fibrosis-driven disease progression in recessive dystrophic epidermolysis bullosa
Alessia Primerano, Emanuela De Domenico, Francesca Cianfarani, et al.
British Journal of Dermatology (2024) Vol. 191, Iss. 4, pp. 568-579
Open Access | Times Cited: 4
Differential modulations of miRNAs in patients with systemic sclerosis-associated skeletal muscle loss
Federica Tambaro, Antonietta Gigante, Carmen Gallicchio, et al.
European Journal of Internal Medicine (2025)
Closed Access
Antifibrotic therapeutic strategies in systemic sclerosis: Critical role of the Wnt/β-catenin and TGF-β signal transduction pathways as potential targets
Leyla Bagheri, Mohammad Javanbakht, Sheida Malekian, et al.
European Journal of Pharmacology (2025), pp. 177607-177607
Closed Access
Clonal haematopoiesis is increased in early onset in systemic sclerosis
Laure Ricard, Pierre Hirsch, Laëtitia Largeaud, et al.
Lara D. Veeken (2020) Vol. 59, Iss. 11, pp. 3499-3504
Closed Access | Times Cited: 30
Gremlin: a complex molecule regulating wound healing and fibrosis
Steven O’Reilly
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 24, pp. 7917-7923
Open Access | Times Cited: 24
The profiles of miRNAs and lncRNAs in peripheral blood neutrophils exosomes of diffuse cutaneous systemic sclerosis
Liya Li, Xiaoxia Zuo, Di Liu, et al.
Journal of Dermatological Science (2020) Vol. 98, Iss. 2, pp. 88-97
Closed Access | Times Cited: 27
A story of fibers and stress: Matrix‐embedded signals for fibroblast activation in the skin
Mugdha Sawant, Boris Hinz, Katrin Schönborn, et al.
Wound Repair and Regeneration (2021) Vol. 29, Iss. 4, pp. 515-530
Closed Access | Times Cited: 23
The contribution of epigenetics to the pathogenesis and gender dimorphism of systemic sclerosis: a comprehensive overview
Bianca Saveria Fioretto, Irene Rosa, Eloisa Romano, et al.
Therapeutic Advances in Musculoskeletal Disease (2020) Vol. 12
Open Access | Times Cited: 23
microRNA27a-3p mediates reduction of the Wnt antagonist sFRP-1 in systemic sclerosis
John Henderson, Sarah Wilkinson, Stefan Przyborski, et al.
Epigenetics (2020) Vol. 16, Iss. 7, pp. 808-817
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top